U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359885) titled 'Prediction of Postoperative Pulmonary Complications in Thoracic Surgery' on Jan. 14.
Brief Summary: Lung cancer is a common disease, and its treatment is lobectomy or pulmonary segmentectomy. In France, approximately 8,000 patients undergo this procedure each year, but it remains associated with significant Postoperative Pulmonary Complications (PPC). This surgical trauma triggers a multicellular and orchestrated immune response, necessary for defense against pathogens, as well as for inflammatory resolution and wound healing. Preoperative single-cell analysis of the patient's immune system is therefore a promising strategy for iden...